Seres Therapeutics, Inc. (MCRB)
Nasdaq: MCRB · Pharmaceutical Preparations · Cambridge, MA · filing with the SEC since 2014
Filings
298 filings since 2017 beside 302 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by May 15, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 35 days after the quarter ended. The proxy statement was last filed Apr 27, 2026.
Filings a yearinsider forms included
5368447060896357
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 9 times in the last 36 months, the newest Oct 26, 2026.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Nov 13, 2024.Debt trigger or default notice (8-K item 2.04): 1 time in the last 36 months, the newest May 7, 2024.SEC letters: 2 in the last 36 months, the newest Oct 9, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 4, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Aug 4, 2026
8-K items 1.01, 1.02, 9.01
Major agreement signed; Major agreement ended · Current report
Jul 31, 2026
Jul 8, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
Jul 8, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Jun 5, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Jun 2, 2026
Mar 12, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Nov 5, 2025
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Aug 6, 2025
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
May 7, 2025
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Apr 22, 2025
8-K items 5.03, 9.01
Charter, bylaw or fiscal-year change · Current report
Apr 21, 2025
Apr 14, 2025
8-K items 5.02, 5.07, 8.01, 9.01
Officer or director change; Shareholder vote; Other event · Current report
Apr 10, 2025
Mar 13, 2025
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
40 of 298 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.